In gastric cancer, glutathione peroxidase‐2 supports tumor progression through the KYNU‐Kyn‐AhR signaling pathway, while glutathione peroxidase‐2 knockdown suppresses tumor growth and metastasis [131]. Here, AHR is linked to neoplasm.